Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Technology insight: will systems pathology replace the pathologist?

Olivier Saidi1, Carlos Cordon-Cardo, Jose Costa

  • 1Aureon Laboratories Inc., Yonkers, NY, USA.

Nature Clinical Practice. Urology
|January 11, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SECmeres outperform extracellular vesicles as potential blood RNA biomarkers for Alzheimer's disease.

Nature communications·2026
Same author

Upper-Extremity Deep Vein Thrombosis in Cancer: Beyond a Catheter-Related Complication.

JACC. CardioOncology·2026
Same author

Early vs Delayed Extubation After Thrombectomy for Acute Ischemic Stroke: The EDESTROKE Randomized Clinical Trial.

JAMA neurology·2026
Same author

A Tumor-Promoting Inflammatory SPP1+ Macrophage-IL6-CRP Axis Drives Immune Dysfunction in Bladder Cancer.

Cancer discovery·2026
Same author

Author Correction: Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion.

Nature genetics·2026
Same author

Inherited Thrombophilia and the Risk of Venous Thromboembolism in Patients with Non-Small Cell Lung Cancer, a Case-Control Study.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026
Same journal

The management of renal angiomyolipomas in a patient with tuberous sclerosis.

Nature clinical practice. Urology·2009
Same journal

Inappropriate treatment of prostate cancer caused by heterophilic antibody interference.

Nature clinical practice. Urology·2009
Same journal

Management of posterior urethral disruption injuries.

Nature clinical practice. Urology·2009
Same journal

Utilization of lean management principles in the ambulatory clinic setting.

Nature clinical practice. Urology·2009
Same journal

Bladder cancer in the elderly: clinical outcomes, basic mechanisms, and future research direction.

Nature clinical practice. Urology·2009
Same journal

Bush's 'parting gifts'.

Nature clinical practice. Urology·2009
See all related articles

Systems pathology offers personalized prostate cancer treatment recommendations by integrating diverse data. This approach predicts tumor behavior and patient response, aiding in risk assessment after surgery.

Area of Science:

  • Oncology
  • Computational Pathology
  • Bioinformatics

Background:

  • Prostate cancer management benefits from predictive models.
  • Current methods may not fully capture disease complexity.
  • Personalized therapeutic strategies are increasingly important.

Purpose of the Study:

  • To introduce systems pathology methods for cancer research.
  • To present evidence for systems pathology in predicting prostate cancer recurrence.
  • To highlight the potential for personalized treatment recommendations.

Main Methods:

  • Integration of quantitative data from multiple sources.
  • Application of knowledge engineering and large dataset analysis.
  • Development of predictive models for tumor behavior and therapeutic response.

Related Experiment Videos

Main Results:

  • Systems pathology successfully predicts the risk of recurrence after prostatectomy.
  • Demonstrated the feasibility of a systems pathology approach for personalized cancer care.
  • Provided initial evidence for the predictive power of this strategy.

Conclusions:

  • Systems pathology can guide personalized therapeutic recommendations for prostate cancer patients.
  • This approach enhances the prediction of disease course and treatment response.
  • Further research can leverage systems pathology for improved cancer management.